Variables | Non-APE group (n = 90) | Low-risk APE group (n = 233) | Intermediate- and high-risk APE group (n = 66) | P |
---|---|---|---|---|
Demographic | ||||
 Age, yrs | 62.9 ± 11.5 | 66.7 ± 12.2 | 62.7 ± 13.8 | 0.010 |
 Male, n (%) | 41(45.6) | 80(34.3) | 30(45.5) | 0.086 |
 Smoking, n (%) | 33(36.7) | 33(14.2) | 13(19.7) |  < 0.001 |
 Drinking, n (%) | 28(31.1) | 14(6.0) | 9(13.6) |  < 0.001 |
Clinical | ||||
 Hypertension, n (%) | 61(67.8) | 143(61.4) | 37(56.1) | 0.317 |
 Diabetes, n (%) | 25(27.8) | 35(15.0) | 11(16.9) | 0.027 |
 Hyperlipidemia, n (%) | 60(66.7) | 116(49.8) | 37(56.1) | 0.023 |
 CAD, n (%) | 62(68.9) | 74(31.8) | 18(27.3) |  < 0.001 |
 SBP, mmHg | 131.8 ± 20.1 | 131.7 ± 22.9 | 115.8 ± 21.4 |  < 0.001 |
 Heart rate, beats/min | 71.4.0 ± 13.2 | 81.7 ± 17.7 | 95.2 ± 20.2 |  < 0.001 |
 Right ventricular diameter, mm | 22.5 ± 4.0 | 25.6 ± 6.0 | 28.0 ± 5.5 |  < 0.001 |
 LVEF, % | 61.3 ± 9.2 | 60.6 ± 8.5 | 59.7 ± 7.8 | 0.514 |
 RV/LV | 0.45(0.42, 0.50) | 0.51(0.46, 0.66) | 0.63(0.53, 0.75) |  < 0.001 |
 PAOI (%) | 0(0, 0) | 47.5(25.0, 67.5) | 70.0(60.0, 75.0) |  < 0.001 |
Laboratory | ||||
 TC, mmol/L | 4.0 ± 1.0 | 4.3 ± 1.0 | 4.4 ± 1.1 | 0.018 |
 TG, mmol/L | 1.4(1.1, 2.0) | 1.4(1.1, 1.8) | 1.4(1.1, 2.0) | 0.471 |
 LDL-C, mmol/L | 2.3(1.8, 2.9) | 2.7(2.2, 3.2) | 2.8(2.2, 3.4) |  < 0.001 |
 HsCRP, mg/L | 2.1(1.1, 3.6) | 6.2(3.0, 10.9) | 11.1(5.6, 12.8) |  < 0.001 |
 Creatinine, µmol/L | 79.1 ± 24.0 | 79.4 ± 20.6 | 80.6 ± 19.4 | 0.904 |
 AST, U/L | 20.0(16.0, 25.0) | 23.0(18.0, 32.0) | 22.0(16.0, 36.2) | 0.005 |
 ALT, U/L | 21.0(14.0, 31.0) | 21.0(13.0, 37.0) | 28.0(17.8, 43.2) | 0.052 |
 WBC, 109 cells/L | 5.9(5.2, 7.6) | 7.6(6.3, 9.2) | 10.0(8.4, 11.9) |  < 0.001 |
 Percentage of neutrophils, % | 61.0 ± 7.3 | 68.4 ± 10.1 | 73.1 ± 9.3 |  < 0.001 |
 Neutrophils, 109 cells/L | 3.7(2.9, 4.8) | 5.1(3.9, 6.6) | 7.2(6.1, 9.1) |  < 0.001 |
 Percentage of lymphocytes, % | 28.5(25.5, 33.3) | 22.2(16.9, 29.1) | 17.8(13.8, 23.4) |  < 0.001 |
 Lymphocytes, 109 cells/L | 1.8(1.5, 2.2) | 1.6(1.3, 2.1) | 1.9(1.4, 2.2) | 0.090 |
 Monocytes, 109 cells/L | 0.4(0.3, 0.5) | 0.4(0.3, 0.6) | 0.5(0.4, 0.7) |  < 0.001 |
 PLT, 109/L | 208.0(174.8, 258.5) | 206.0(158.5, 243.0) | 201.0(168.5, 256.8) | 0.617 |
 NLR | 2.1(1.7, 2.6) | 3.1(2.2, 4.5) | 4.2(2.7, 5.8) |  < 0.001 |
 PLR | 118.1(92.4, 146.3) | 119.4(90.2, 166.1) | 124.2(90.2, 143.3) | 0.692 |
 HGB, g/L | 137.3 ± 18.6 | 134.5 ± 17.8 | 138.2 ± 19.3 | 0.236 |
 RDW, % | 13.0(12.3, 13.4) | 13.1(12.4, 14.0) | 13.0(12.5, 13.9) | 0.115 |
 D-dimer, ng/mL | 0.9(0.5, 1.2) | 3.1(1.7, 6.1) | 5.9(2.7, 8.6) |  < 0.001 |
 NT-proBNP, pg/mL | 139.0(88.9, 294.9) | 533.8(144.7, 1268.05) | 2093.9(787.8, 3386.3) |  < 0.001 |
Medications | ||||
 Statins, n (%) | 60(66.7) | 49(21.0) | 15(22.7) |  < 0.001 |
 Aspirin, n (%) | 53(58.9) | 34(14.6) | 9(13.6) |  < 0.001 |
 ARB/ACEI, n (%) | 42(46.7) | 57(24.5) | 12(18.2) |  < 0.001 |
 β-blocker, n (%) | 52(57.8) | 49(21.0) | 13(19.7) |  < 0.001 |
 Calcium Antagonists, n (%) | 36(40.0) | 45(19.3) | 15(22.7) | 0.001 |
 Diuretics, n (%) | 16(19.3) | 21(9.0) | 7(10.6) | 0.082 |